EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Insight Into the Significance of CD8 + Tumor‐Infiltrating Lymphocytes in Lung Adenocarcinoma

Kazu Shiomi iD, Masaaki Ichinoe, Ai Ushiwata, Ryo Nagashio, Shoko Hayashi, Dai Sonoda iD, Yasuto Kondo, Satoru Tamagawa, Shunsuke Mitsuhashi, Yuka Sugiyama, Masahito Naito, Masashi Mikubo und 6 weitere

Thoracic Cancer · 2025

DOI: 10.1111/1759-7714.70135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Kazu Shiomi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-Shi, Kanagawa, Japan. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Adenocarcinoma of Lung, CD8-Positive T-Lymphocytes, Lung Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite great expectations regarding the use of tumor‐infiltrating lymphocytes (TILs) in predicting the effects of immunotherapies and prognosis, knowledge about TILs remains inadequate for clinical application. We re‐evaluated the clinicopathological significance of CD8+ tumor‐infiltrating lymphocytes (CD8 + TILs) in lung adenocarcinoma from a novel perspective and through a more objective approach using cell counting software.

Methods

Among patients with surgical resection of lung adenocarcinoma in 2011–2017, 156 patients with pathological stage IB–III were immunohistochemically studied to evaluate CD8 + TILs in the tumor stroma. The impact of CD8 + TILs on relapse‐free survival was analyzed by Kaplan–Meier survival and multivariate Cox proportional hazards analyses.

Results

Our analysis showed that patients with large numbers of CD8 + TILs in the stroma are not a homogeneous population and include subpopulations with a poor prognosis. Furthermore, our study showed important findings about the overall inflammatory status in the tumor microenvironment based on the association between the number of CD8 + TILs and the frequency of vascular invasion. Additionally, CD8 + TILs were shown to potentially be more effective than PD‐L1.

Conclusions

Our study demonstrated that in lung adenocarcinoma, even among populations with abundant CD8 + TILs in the tumor stroma, there may be a poor prognostic subgroup. Furthermore, we revealed a partial yet important relationship between CD8 + TILs and the tumor microenvironment. A more detailed investigation into the significance of CD8 + TILs may lead to a deeper understanding of the inflammatory status of the tumor microenvironment and ultimately contribute to the identification of appropriate biomarkers for prognostic prediction and assessing the efficacy of immune checkpoint inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingAdenocarcinoma of LungCD8-Positive T-LymphocytesLung NeoplasmsHumansMaleFemaleMiddle AgedPrognosisAgedTumor Microenvironment

Stichwörter der Autor:innen

biomarkerimmune checkpoint inhibitorslung cancertumor microenvironmenttumor‐infiltrating lymphocytes

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-Shi, Kanagawa, Japan.
  • Department of Pathology, Kitasato University School of Medicine, Sagamihara-Shi, Kanagawa, Japan.
  • Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
  • Department of Applied Tumor Pathology, Graduate School of Medical Sciences, Kitasato University, Sagamihara-Shi, Kanagawa, Japan.
  • Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara-Shi, Kanagawa, Japan.
  • Department of Biosciences, Kitasato University School of Sciences, Sagamihara-Shi, Kanagawa, Japan.

ORCID-Profile: Kazu Shiomi, Dai Sonoda, Takashi Sato

Zitieren

APA

Shiomi, K., Ichinoe, M., Ushiwata, A., Nagashio, R., Hayashi, S., Sonoda, D., Kondo, Y., Tamagawa, S., Mitsuhashi, S., Sugiyama, Y., Naito, M., Mikubo, M., Shirasawa, M., Nakahara, Y., Sato, T., Naoki, K., Murakumo, Y., & Eshima, K. (2025). Insight Into the Significance of CD8 + Tumor‐Infiltrating Lymphocytes in Lung Adenocarcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70135

Vancouver

Shiomi K, Ichinoe M, Ushiwata A, Nagashio R, Hayashi S, Sonoda D, et al. Insight Into the Significance of CD8 + Tumor‐Infiltrating Lymphocytes in Lung Adenocarcinoma. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70135

BibTeX
@article{Shiomi2025,
  author = {Shiomi, Kazu and Ichinoe, Masaaki and Ushiwata, Ai and Nagashio, Ryo and Hayashi, Shoko and Sonoda, Dai and Kondo, Yasuto and Tamagawa, Satoru and Mitsuhashi, Shunsuke and Sugiyama, Yuka and Naito, Masahito and Mikubo, Masashi and Shirasawa, Masayuki and Nakahara, Yoshiro and Sato, Takashi and Naoki, Katsuhiko and Murakumo, Yoshiki and Eshima, Koji},
  title = {Insight Into the Significance of CD8 + Tumor‐Infiltrating Lymphocytes in Lung Adenocarcinoma},
  journal = {Thoracic Cancer},
  year = {2025},
  doi = {10.1111/1759-7714.70135}
}
Kostenlos starten →